Argenta Discovery Ltd.

Financings During the opening quarter of 2014, biopharma companies raised $9.8 billion (up 53% from Q4), with 18% of the deals having a value of $100 million or greater. ( See Exhibit 1. ) Follow-on p

IN VITRO DIAGNOSTICS Mergers & Acquisitions Oxford Gene Technology Ltd. Cytocell Technologies Ltd. Genetics research and biomarker discovery firm Oxford Gene Technology Ltd. (OGT) bought fellow UK

The pharmaceutical division of Teijin has acquired rights in Japan to Pulmagen Therapeutics' lead CRTh2 antagonist ADC3680, which it will develop initially for bronchial asthma. The deal is the first

French company Servier and Belgium's Galapagos have entered into a multi-year strategic alliance to discover and develop new small molecule therapies for cancer, building on their existing relationshi